Sweet enhancing effect of neohesperidin dihydrochalcone (NHDC) or cyclamate has been reported to be synergistic in human sensory tests. However, little is known about whether these synergisms are caused by the mechanism mediated by the human sweet-taste receptor. Here, we examined the sweetness intensity of sweet tastant mixtures by measuring the responses of cultured cells stably expressing the human sweet-taste receptor. The results showed that the cell response to sucrose was synergistically potentiated by the addition of NHDC or cyclamate. Moreover, a point mutation in the transmembrane domain of hT1R3 almost completely eliminated the enhancing effects of NHDC and cyclamate. These results suggest that ligand-receptor interactions in the transmembrane domain of hT1R3 are necessary for NHDC and cyclamate to elicit the synergistic potentiation of the receptor activation. Our results may provide the foundation of a molecular basis for receptor-based synergisms of sweet tastes in mixtures of diverse sweet substances.
Introduction
Sucrose, fructose, glucose and other sugars elicit a distinctive perceptual quality termed sweetness in humans, and these sugars are generally highly preferred to other tastants. The preference for sweet tastes likely exists because sweetness signals foods and beverages with high energy contents (Chandrashekar, Hoon, Ryba, & Zuker, 2006) . However, excess ingestion of sugars can lead to lifestyle-related diseases, such as diabetes and obesity. Sweetness enhancers may prevent the excess ingestion of sugars in foods and beverages, and thus sweet-taste synergisms have been well studied (Birch, 1999; Hutteau, Mathlouthia, Portmann, & Kilcast, 1998; Parke, Birch, Portmann, & Kilcast, 1999; Schiffman et al., 1995) .
In mammals, sweet taste perception is mediated by G proteincoupled receptors (GPCRs) T1R2 (taste type 1 receptor 2) and T1R3 (taste type 1 receptor 3). T1Rs belong to the class C GPCRs and are distantly related to the calcium sensing receptor, metabotropic glutamate receptors, V2R pheromone receptors and GABAB receptors. Class C GPCRs are hetero-or homo-dimeric receptors with a large extracellular domain (ECD) chiefly responsible for agonist recognition and binding, composed of two domains: the Venus flytrap module (VFTM) and the cysteine-rich domain (CRD). The VFTM is a two-lobed clamshell-like structure, and the CRD lies between the VFTM and the transmembrane domain (TMD) (Pin, Galvez, & Prezeau, 2003) . It has also been reported that differences in sweet taste perception according with molecular species depend on structural variations of the taste receptor. Studies with chimeric receptors or mutations in the taste receptor have revealed that the sweet-taste receptor has multiple putative ligand-binding sites (Temussi, 2007) . For example, aspartame is recognised at the extracellular domain of human T1R2 (hT1R2) (Xu et al., 2004) , and NHDC and cyclamate are bound at the TMD of hT1R3 Winnig, Bufe, Kratochwil, Slack, & Meyerhof, 2007; Xu et al., 2004) . Sweet proteins, such as monellin, brazzein (Assadi-Porter, Tonelli, Maillet, Markley, & Max, 2010; Jiang et al., 2004) and neoculin (Koizumi et al., 2007) have been shown to interact with the extracellular domain of hT1R3. These actions modify or stabilise the receptor conformation at helical transmembrane region for the activation of the G-protein. Thus, our detailed molecular understanding of the interactions between the sweet taste receptor and sweeteners may contribute to the rational design of analogues with improved sensory properties.
Soon after the first characterisation of taste receptors Hoon et al., 1999) , taste stimuli including sweet, bitter, sour and umami were measured in these receptors when heterologously expressed in cultured cells (Bufe, Hofmann, Krautwurst, Raguse, & Meyerhof, 2002; Chandrashekar et al., 2000; Ishii et al., 2009; Ishimaru et al., 2006; Nelson et al., 2001; Zhao et al., 2003) . This assay system has allowed researchers to clarify not only these receptors' cognate ligands but also the biochemical basis for taste modulation, such as the inhibition of sweet (Jiang, Cui, Zhao, Liu et al., 2005) or bitter tastes (Sakurai et al., 2009; Slack et al., 2010) , and also umami synergism (Zhang et al., 2008) . Recently, several papers have been also mentioned to the biochemical basis for sweet-taste synergism (Morini, Bassoli, & Temussi, 2005; Servant et al., 2010; Zhang et al., 2010) . For instance, Servant et al. (2010) reported novel sweet-taste enhancers (SE-1, SE-2 and SE-3) whose effects were demonstrated not only by taste tests but also by receptor-based assays of sweetness intensities. Moreover, Zhang et al. clarified that these sweet enhancers (SE-1, SE-2 and SE-3) further stabilised the active conformation of the receptor by interacting with the extracellular domain of T1R2 . These findings provided the beginnings of a rational basis for the complexity of the sweet-taste synergisms observed with chemically diverse sweeteners.
Sweet-taste synergisms have been studied in mixtures of sweeteners that elicit potentiation of sweet taste. Previous psychophysical studies have revealed that the addition of neohesperidin dihydrochalcone (NHDC) or cyclamate resulted in an overadditive enhancement of the perceived sweetness of a sucrose solution (Birch, 1999; Hutteau et al., 1998; Parke et al., 1999; Schiffman et al., 1995) . In this study, we verified the potentiating effects of NHDC and cyclamate on the allosteric activation of the sweet-taste receptor by measuring the responses of Flp-In 293 cells expressing functional human sweet-taste receptors (Imada et al., 2010) . We also examined whether or not the ligand-receptor binding site in the TMD of hT1R3 is necessary for NHDC and cyclamate to elicit a potentiation of sweetness. Our findings here might propose a rational basis for receptor-based mechanism of sweet-taste synergism and also provide an effective approach for finding optimal pairings of chemically diverse sweeteners that can cause a synergistic enhancement of sweet taste.
Materials and methods

Sweet molecules and solutions
The sweeteners used in this study were purchased as follows: NHDC, glycyrrhizic acid trisodium salt and stevioside from Tokyo Kasei Kogyo Co., Ltd., Japan; thaumatin, sucralose, aspartame, saccharin Na and acesulfame K from Wako Chemical Co., Japan; dulcin from Kanto Chemical Co., Ltd., Japan; neotame from NutraSweet Co., USA; rebaudioside A from Morita Kagaku Kogyo, Japan; sodium cyclamate from Sigma Aldrich, USA; and sucrose from Nacalai Tesque, Japan.
The assay buffer was composed of 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 130 mM NaCl, 10 mM glucose, 5 mM KCl, 2 mM CaCl 2 and 1.2 mM MgCl 2 (pH adjusted to 7.4 using NaOH). Ligands were diluted into the assay buffer at the desired concentrations.
Cell culture of the human sweet-receptor-expressing cells
Flp-In 293 cells stably expressing hT1R2/hT1R3 along with Ga16gust44 were generated as described previously (Imada et al., 2010) . Stable cell lines expressing the wild-type (WT) human sweet-taste receptor or its mutant forms (hT1R2/hT1R3 A733V or hT1R2/hT1R3 F778A) were generated as in the previous report (Imada et al., 2010) . The cells were maintained in low-glucose (1.0 g/l) Dulbecco's modified Eagle's medium (Sigma Aldrich, St. Louis, MO) with 10% fetal bovine serum (Invitrogen, Carlsbad, CA).
Measurement of cellular responses by calcium-imaging analysis
For fluorescence microscopy, cells were first seeded onto 96-well plates (Lumox multiwell 96-well, Starstedt AG and Co., Nümbrecht, Germany) at approximately 50,000 cells per well. After 20-26 h, the cells were washed with assay buffer and then loaded with 5 lM of fura-2-acetoxymethyl ester (fura-2AM; Invitrogen) in assay buffer for 30 min at 27°C. The cells were again washed with assay buffer and incubated in 100 ll of assay buffer for up to 15 min at room temperature. The cells were stimulated with sweet tastants by adding 100 ll of 2Â ligand, i.e., double-strength ligand solution.
The intensities of fura-2 fluorescence emissions resulting from excitations at 340 and 380 nm were measured at 510 nm using a computer-controlled filter exchanger (Lambda 10-3; Sutter, San Rafael, CA, USA), a CoolSNAP HQ2 charge-coupled device camera (Photometrics, Tucson, AZ, USA), and an inverted fluorescence microscope (IX-71; Olympus, Tokyo, Japan). The images were recorded at 4-s intervals and analysed using MetaFluor software (Molecular Devices Co., Sunnyvale, CA, USA). Changes in the intracellular calcium ion concentration were estimated from changes in the ratio of the fluorescence intensities at the two excitation wavelengths (F 340 /F 380 ).
Measurement of cellular responses by cell-based assay
Multiple data points and dose-response curves were generated in the cell-based assay using a FlexStation 3 (Molecular Devices Co., Sunnyvale, CA, USA). For the multiwell assays, cells were seeded onto 96-well plates (clear-bottomed CellBIND surface plate, Corning Inc., Bedford, MA, USA) at approximately 80,000 cells per well. Cells were washed with assay buffer prior to loading with a calcium-indicator dye from the FLIPR Calcium 4 Assay Kit (Molecular Devices) by dilution with the assay buffer. The cells were incubated for 45 min at 27°C, after which measurements were made using a FlexStation 3 (Molecular Devices). Fluorescence changes (i.e., excitation at 485 nm and emission at 525 nm with a cutoff at 515 nm) were monitored at 2-s intervals. A 100-ll aliquot of assay buffer supplemented with 2Â ligands was added at 20 s, and scanning was continued for an additional 100 s. The response of each well was determined as DRFU (delta relative fluorescent units), calculated as (maximum fluorescent value) À (minimum fluorescent value). The data are reported as the mean ± S.E.M. of the DRFU. Fitting curves for dose-response data and its correlation coefficient values were calculated with Clampfit 9.2 (Axon Instruments) using Hill's equation.
Results and discussion
Receptor-based sweet taste synergisms of NHDC or cyclamate
Psychophysical investigations have revealed that mixtures of certain sweeteners, such as sucrose plus NHDC or sucrose plus cyclamate, elicit a synergistic enhancement of sweet taste (Birch, 1999; Hutteau et al., 1998; Parke et al., 1999; Schiffman et al., 1995) . To investigate whether these sweet-taste synergisms were also observed in a heterologously expressed human sweet-taste receptor, we carried out Ca 2+ imaging analyses that measured the responses of Flp-In 293 cells stably expressing hT1R2 and hT1R3 together with a chimeric G protein, Ga16gust44, to sweet tastants (Fig. 1) . Here, we used sucrose as a sweetener to be enhanced because it is representative of the sweet tastants used in the food industry. Although The significances for the differences between control (sucrose alone) and test values were determined using one-way ANOVA followed by Dunnett's test. ⁄⁄ p < 0.01 vs. sucrose alone.
NHDC and cyclamate are known as sweeteners themselves, the concentrations used here (0.03 mM NHDC or 1 mM cyclamate) were confirmed to elicit only a weak response in cells expressing human sweet-taste receptors when each was applied to the cells alone (Fig. 1A-e and i) . Sucrose elicited a response in human sweet-taste receptor-expressing cells in a dose-dependent manner. When 50-150 mM of sucrose was applied to the cells, the cell response mediated by the sweet-taste receptor was clearly present (Fig. 1A-b-d) ; this effect was verified by the inhibition of the response in the presence of 1 mM lactisole, which is an inhibitor of the human sweettaste receptor (data not shown). In the presence of 0.03 mM NHDC (Fig. 1A-f-h ) or 1 mM cyclamate (Fig. 1A-j-l) , the number of responding cells increased noticeably; we confirmed that the effects were significant by calculating the Dratio (F 340 /F 380 ) for each cells in the images of Ca imaging analysis (Fig. 1B) .
Next, to compare the effects of adding various sweeteners to the sucrose solution, we examined the dose-response profiles for sucrose (0-100 mM) in the absence and presence of various concentrations of the sweeteners (Fig. 2) . The concentrations of sweeteners added were determined so as to faintly or weakly activate the human sweet taste receptor; the determination was based on the dose-response profiles of sweet taste receptor-expressing cells for each sweetener (Fig. S1 ). According to the result, each sweetener was added to sucrose solution as follows: aspartame, 0.1, 0.3, 1 mM; saccharin, 0.03, 0.1, 0.3 mM; acesulfame K, 0.1, 0.3, 1 mM; NHDC, 0.01, 0.03, 0.1 mM; and cyclamate, 0.3, 1, 3 mM. The cell responses were observed to be the same when each sweetener was applied to the cells at the given concentrations as follows, aspartame, 0.3 mM; saccharin, 0.1 mM; acesulfame K, 0.3 mM; NHDC, 0.03 mM; and cyclamate, 1 mM (Fig. 2F ).
When each of aspartame (0.1 or 0.3 mM), saccharin (0.03 or 0.1 mM), or acesulfame K (0.1 or 0.3 mM) was added to sucrose, the cellular response slightly increased with no significant difference from the case of sucrose alone ( Fig. 2A-C) . Moreover, when each of 1 mM aspartame, 0.3 mM saccharin, or 1 mM acesulfame K was added at a concentration that weakly activated the human sweet taste receptor, only an additive effect was observed ( Fig. 2A-C) . Moreover, when those sweeteners were added at a concentration, which weakly activated the human sweet taste receptor (1 mM aspartame, 0.3 mM saccharin, or 1 mM acesulfame K), only additive effects could be observed ( Fig. 2A-C) . Comparing to these results, when NHDC or cyclamate was added to sucrose, the responses increased significantly (Fig. 2D-F) . This result strongly indicated that NHDC and cyclamate have distinct effects on the cell response to sucrose, compared to other sweeteners, such as aspartame, saccharin and acesulfame K.
To clearly demonstrate synergism rather than additive effect of NHDC and cyclamate, we examined the difference between the DRFU value of 'sucrose + sweetener' and the sum of 'sucrose alone' + 'sweetener alone' by calculating 95% two-sided confidence intervals (Table S1 ). The criteria for the synergism was defined according to the publication by Schiffman et al. (1995) . For any given mixture of sucrose and sweetener, if the lower confidence limit of the amplitude of 'sucrose + sweetener' fell above the average of sum of 'sucrose alone' + 'sweetener alone', the effect is concluded as synergistic (Schiffman et al., 1995) . Since only a part of coupling with NHDC or cyclamate was defined as synergistic in our experimental data, enhancing effects of NHDC and cyclamate on sweet receptor activation were more than a simple additive effect, when mixed with sucrose (Table S1 ). On the other hand, such effects of The response to sucrose (0, 50, 100 mM) in the absence and presence of various sweeteners. The significances for differences between the control (sucrose alone) and test values were determined using one-way ANOVA followed by Dunnett's test.
⁄ p < 0.05, or ⁄⁄ p < 0.01 vs. sucrose alone, respectively.
other sweeteners above appeared to be simply an additive effect (Table S1 ). In the sensory data by Schiffman et al. (1995) , sweet taste synergisms in binary mixtures of sweeteners at concentrations isosweet with 3% sucrose (i.e., 88 mM sucrose) were investigated. This study showed that the sweet enhancing effect of NHDC and cyclamate on 3% sucrose was determined to be synergistic, whereas the effects of aspartame, acesulfame K and saccharin was no more than additive. Our receptor assay described in this study was totally well correlated with this sensory data. In detail, NHDC or cyclamate at the concentration with same sweetness around 3% sucrose (i.e., 0.033 mM for NHDC and for 5.07 mM cyclamate) induces a synergistic enhancement of sweetness when each of them was added to 50 or 100 mM (i.e., 1.7% or 3.4%, respec- Each bar indicates the mean ± S.E.M. from three independent experiments. The significances for the differences between the control (sweetener alone) and test values were determined using one-way ANOVA followed by Dunnett's test.
⁄ p < 0.05, ⁄⁄ p < 0.01, or ⁄⁄⁄ p < 0.001 vs. each sweetener alone, respectively. tively) sucrose solution. Accordingly, our data implies a strong association with the sweet intensity to the activation of sweet taste receptor, also indicating that the sweet enhancing of NHDC or cyclamate is just a result of the receptor-based synergisms.
The action mechanisms of the receptor-based sweet taste synergisms
NHDC and cyclamate have been reported to interact with the TMD of hT1R3 when they elicit the sweetness of their own, whereas aspartame, saccharin and acesulfame K are reported to bind to the VFTM of hT1R2 (Galindo-Cuspinera, Winnig, Bufe, Meyerhof, & Breslin, 2006) . To examine whether the sweetnesspotentiating effects of NHDC and cyclamate were derived from receptor-ligand interactions in the TMD of hT1R3, we utilised a cell line expressing mutant sweet-taste receptors, each with a point mutation in the hT1R3 TMD subunit (F778A and A733V). F778A was reported as a mutant with a reduced ability to recognise NHDC and cyclamate (Winnig et al., 2007) . On the other hand, A733V does not affect the ability to recognise NHDC and cyclamate, and was then used as a positive control here. We also examined the response of our stable cell lines to sucrose, NHDC and cyclamate, and confirmed the previously reported results with these mutations (Fig. S2A) . As shown in Fig. 3 , the potentiating effect of NHDC or cyclamate was also observed when the cell line expressing the A733V mutant, as in the case with the WT receptor. In both cases, the cellular response to sucrose increased by the addition of 0.03 mM NHDC or 1 mM cyclamate. In contrast, the response of the F778A-expressing cells to sucrose was almost equal to the case that NHDC or cyclamate was added (Fig. 3) . Furthermore, for the F778A mutant receptor, the enhancing effect of NHDC or cyclamate was completely diminished to the case of 0.1 mM NHDC or 3 mM cyclamate (Fig. S2B ). These observations suggest that the F778 residue in hT1R3 is critical for NHDC and cyclamate not only to activate the human sweet-taste receptor, but also to elicit synergistic potentiation to sucrose. Noting that the transmembrane domains six and seven are generally important for GPCR activation (Hu et al., 2005; Malherbe et al., 2003; Petrel et al., 2003) and that their activation is often derived from conformational changes in the TMDs, our results proposed that this mechanism is probably true for hT1R activation. Interestingly, F778 in hT1R3 TM6 is also known as an essential site for the action of lactisole, which is a wide-acting inhibitor of the human sweet-taste receptor (Jiang, Cui, Zhao, Liu et al., 2005; Winnig et al., 2007) . This fact indicated that an interaction with F778 is not an implicit factor for sweet taste modulator to act as agonist or inhibitor. Accordingly, it is likely that a residue other than F778 in the TMD of hT1R3 determines the direction of the modulation such as NHDC (i.e., sweet enhancer) or lactisole (i.e., sweet inhibitor). Further studies are needed to clarify the roles of mobility and G-coupling in the TMD in relation to the allosteric modulation of hT1R2/hT1R3.
The potentiating effects of NHDC and cyclamate on various sweeteners
In order to evaluate the potentiating effects of NHDC or cyclamate on various sweeteners, the cell responses of the WT human sweet-receptor-expressing cells on several additional sweeteners with or without the enhancer were observed (Fig. 4) . The additional sweeteners used here were dipeptide, terpenoid glycoside, protein and small-molecule-sweetener. The final concentrations of each sweetener tested here were as follows: 0.01 mM neotame, 0.3 mM rebaudioside A, 0.3% thaumatin, 0.3 mM sucralose, 1 mM aspartame, 0.3 mM saccharin Na, 1 mM acesulfame K, 0.1 mM stevioside, 0.3 mM glycyrrhizic acid trisodium, 0.1 mM dulcin, 3.3 mM NHDC and 7.5 mM cyclamate. The final concentrations used were determined to be concentrations near their EC 50 values. Addition of 0.03 mM NHDC and 1 mM cyclamate showed significant enhancements of the receptor response to all of the sweeteners tested (Fig. 4) . The values of DRFU for each sweetener were changed from 1.3-to 1.8-fold by the addition of 0.03 mM NHDC, and from 1.4-to 2.0-fold by the addition of 1 mM cyclamate, respectively. As shown in Fig. 4 , the potentiation caused by NHDC or cyclamate was shown to be effective for various sweeteners; even the potentiation by NHDC was effective for cyclamate and vice versa (Fig. S2) , the potentiating effect of NHDC could be fully detected even at low concentrations, such as 0.03 mM (Figs. 1  and 2 ). The development of such agents that can widely act at low concentration is of critical importance, because it could be advantageous in reducing unintentional influences, such as after taste and other side effects, when added to food and drinks as a taste modulator.
Considering that sucrose, aspartame, saccharin and acesulfame K interact with the extracellular domain in hT1R2 (Galindo-Cuspinera et al., 2006) , different from NHDC and cyclamate, which interact with the TMD of hT1R3, our results lead to concluding that a binary mixture of sweeteners, each of which interacts with the TMD of hT1R3, can elicit an overadditive potentiation to induce a receptor-based synergism of sweet-taste. These results may also imply the importance of the ligand-receptor interaction at the TMD of hT1R3 to induce the synergistic potentiation of the gustatory receptor dimer composed of hT1R2 and hT1R3 (Fig. 5) .
Recently, Servant et al. (2010) discovered novel sweet-taste enhancers (SE-1, SE-2 and SE-3), which were positive allosteric modulators for the receptor dimer of hT1R2/hT1R3. These substances were also confirmed to enhance sweet-taste intensity in human sensory tests . Compared to these enhancers, NHDC and cyclamate have several distinct features in their efficacy and working mechanisms as follows. First, while the effect of SE-1 was restricted to the response of the human sweet-taste receptor-expressing cells to neotame, sucrose and sucralose, the effects of NHDC and of cyclamate were observed for all the sweeteners tested in this study (Fig. 4) . Considering that NHDC and cyclamate increased the potencies of various sweeteners in the assay using sweet-receptor-expressing cell, these data may also support the hypothesis that NHDC and cyclamate change the dynamic equilibrium between the active and inactive conformation of the sweet-taste receptor by interacting with the TMD of hT1R3 (Fig. 5 ). Another important difference between NHDC and SE1-3 is in their interaction sites with the sweet-taste receptor. While Servant et al. (2010) showed that SE-1 through SE-3 act as enhancers by interacting with the extracellular domain of hT1R2 using mutagenesis experiments and molecular modelling, NHDC and cyclamate appear to exert their effect by interacting with the TMD of hT1R3 (Fig. 3) . These findings consequently indicated the following possibilities: (a) several mechanisms exist for the potentiation of sweet-taste, and the mechanisms differ widely among NHDC, cyclamate and SE1-3; (b) further enhancement would be expected by the combined use of NHDC, cyclamate and SE1-3, as long as their potentiating effects do not compete.
Conclusions
In summary, we demonstrated that NHDC and cyclamate synergistically enhanced the response of the human sweet-taste receptor to a sucrose solution and also that these enhancing effects were observed in combination with other sweeteners instead of sucrose. Using a mutational analysis, we identified a critical residue for NHDC and cyclamate in eliciting an overadditive potentiation of sweetness. Our observations may provide additional insight into a receptor-based understanding of the complex synergisms of sweet taste and also provide an effective approach to screening high potential sweetness enhancers that could reduce the sugar contents in foods, thereby contributing to the health benefits.
